Given the significance of the VEGF pathway in the development of cancer angiogenesis and the prevalence of VEGF in brain tumors, brain cancer therapies were nearly solely focused on blocking the VEGF pathway [25,26]. This evidence concerns the gene VEGFA and cancer.